基本信息
views: 12
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Jan M. Keppel Hesselink, MD, MSc, PhD received his MSc in biology (cum laude) at the university of Utrecht; his degree in medicine, MD in Utrecht, his PhD (thesis on Parkinson's disease) at the university of Nijmegen, NL.
In 1996 he was appointed professor of molecular pharmacology at the university of Witten/Herdecke (Germany).
He became a member of the British association of psychopharmacology (MBAP) and in the same period he was elected as Fellow of the Pharmaceutical Faculty in Medicine (FFPM) in the UK.
He worked several years at Bayer AG in Germany as VP CNS and business head CNS. He was director at Licentec and advisor scientific R&D as well as business strategies to the Dutch Royal Acadamy of Science (KNAW) and KNAW institutes, such as the Hubrecht Institute, were he assisted spin-outs.
In 2009 he started the Institute for neuropathic pain. Since then 8 different novel topical analgesic creams have been developed, the most recent one based on phenytoin, protected by 2 patents in the PTC phase.
He is currently a consultant for the pharma industry and advices life science investors by conducting DD on IP and coach spin-outs and spin-offs in the R&D focussed on registration NCE's.
Research Interests
Papers共 84 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jan M Keppel Hesselink, Stephen M Stahl
Journal of Mood Disorders and Therapyno. 1 (2019)
Clinical Sciences Research and Reportsno. 1 (2019)
Journal of Case Reports and Medical Images (2018)
Load More
Author Statistics
#Papers: 82
#Citation: 1066
H-Index: 21
G-Index: 29
Sociability: 4
Diversity: 3
Activity: 5
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn